Bull case
KMB would need investors to value it at roughly 17x earnings — about 4x more generous than today's 13x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where KMB stock could go
KMB would need investors to value it at roughly 17x earnings — about 4x more generous than today's 13x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing KMB — at roughly 12x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 5x multiple contraction could push KMB down roughly 37% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Kimberly-Clark is a global manufacturer of personal care and consumer tissue products sold under well-known brands like Huggies, Kleenex, and Scott. It generates revenue primarily through three segments: Personal Care (~50% of sales), Consumer Tissue (~35%), and K-C Professional (~15%), selling to retailers, distributors, and commercial customers. The company's competitive advantage lies in its powerful portfolio of essential household brands with strong consumer loyalty and extensive global distribution networks.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.92/$1.67 | +15.0% | $4.2B/$4.8B | -14.1% |
| Q4 2025 | $1.82/$1.75 | +4.0% | $4.1B/$4.1B | +0.9% |
| Q1 2026 | $1.86/$1.81 | +2.8% | $4.1B/$4.1B | -0.3% |
| Q2 2026 | $1.97/$1.93 | +2.1% | $4.2B/$4.1B | +1.9% |
KMB beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $98 — implies +0.1% from today's price.
| Metric | KMB | S&P 500 | Consumer Defensive | 5Y Avg KMB |
|---|---|---|---|---|
| Forward PE | 12.9x | 19.1x-32% | 15.0x-14% | — |
| Trailing PE | 16.0x | 25.1x-36% | 19.1x-16% | 21.5x-26% |
| PEG Ratio | — | 1.72x | 1.87x | — |
| EV/EBITDA | 12.5x | 15.2x-18% | 11.5x | 14.8x-16% |
| Price/FCF | 19.7x | 21.1x | 14.9x+32% | 21.1x |
| Price/Sales | 1.9x | 3.1x-40% | 0.8x+127% | 2.2x-14% |
| Dividend Yield | 5.13% | 1.87% | 2.79% | 3.80% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolKMB generates $2.6B in free cash flow at a 15.6% margin — 23.3% ROIC signals a durable competitive advantage · returns 5.6% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~2.5 years to full repayment at current FCF run-rate
* Elevated by buyback-compressed equity — compare ROIC (23.3%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Significant increases in pulp, petroleum-based materials, energy, and transportation costs can erode margins. Supplier constraints and consolidation may limit supply sources, potentially disrupting production and sales.
International operations expose KMB to currency fluctuations, political, social, and economic instability. Changes in exchange rates or regulatory restrictions can increase costs and reduce revenue.
KMB’s net debt to EBITDA ratio indicates moderate debt usage, but significant liabilities remain. Interest coverage is strong, yet refinancing risk or rising rates could pressure cash flow.
Intense competition may force price reductions, impacting gross margins. Market share erosion against private-label and lower-cost competitors could reduce earnings.
Negative publicity or product recalls could erode consumer trust in flagship brands like Huggies and Kleenex. Brand damage may lead to declining sales and higher marketing spend.
Climate-related events could disrupt supply chains or increase regulatory costs. The company’s ERM program addresses these risks, but impacts remain uncertain.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
At current prices, KMB trades below its intrinsic value, offering a 40‑50% upside over the next one to two years as valuation normalizes. This rare entry point is supported by long‑term trend and business quality.
Kimberly‑Clark operates in the consumer staples sector, less sensitive to economic downturns. Products such as Huggies, Kleenex, and Depend maintain consistent demand across cycles.
The acquisition of Kenvue creates a “monster” with over $32 billion in annual revenue. Expected cost synergies and margin improvement are viewed as permanent, despite initial market concerns over debt and dilution.
Focused productivity and supply‑chain initiatives have delivered record gains, generating significant cost savings and margin expansion. Management plans to reinvest these efficiencies to expand the global footprint.
KMB is gaining outsized market share in high‑margin international markets, notably China for diapers and Indonesia for femcare products. The company is also recognized as a growth leader in the U.S. CPG market.
The firm generates roughly $1.6 billion in free cash flow annually and has increased its dividend for over 50 consecutive years, underscoring financial robustness.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
KMB KMB Kimberly-Clark Corporation | $32.3B | 12.9x | -5.6% | 12.8% | Hold | +13.2% |
PG PG The Procter & Gamble Company | $338.6B | 21.0x | +0.9% | 14.7% | Buy | +11.7% |
CHD CHD Church & Dwight Co., Inc. | $22.2B | 24.9x | +1.5% | 11.8% | Buy | +6.5% |
ENR ENR Energizer Holdings, Inc. | $1.2B | 5.4x | +1.2% | 6.5% | Hold | +30.0% |
COT COTY Coty Inc. | $2.3B | 9.4x | -0.1% | -9.3% | Hold | +56.6% |
CLX CLX The Clorox Company | $10.4B | 14.7x | -0.4% | 11.2% | Hold | +22.5% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
KMB returns 5.6% total yield, led by a 5.13% dividend, raised 27 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.28 | — | — | — |
| 2025 | $5.04 | +3.3% | 0.4% | 5.4% |
| 2024 | $4.88 | +3.4% | 2.3% | 6.0% |
| 2023 | $4.72 | +1.7% | 0.5% | 4.4% |
| 2022 | $4.64 | +1.8% | 0.2% | 3.6% |
Common questions answered from live analyst data and company financials.
Kimberly-Clark Corporation (KMB) is rated Hold by Wall Street analysts as of 2026. Of 31 analysts covering the stock, 10 rate it Buy or Strong Buy, 18 rate it Hold, and 3 rate it Sell or Strong Sell. The consensus 12-month price target is $110, implying +13.2% from the current price of $97. The bear case scenario is $61 and the bull case is $127.
The Wall Street consensus price target for KMB is $110 based on 31 analyst estimates. The high-end target is $125 (+28.6% from today), and the low-end target is $99 (+1.9%). The base case model target is $94.
KMB trades at 12.9x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for KMB in 2026 are: (1) Raw Material Costs & Availability — Significant increases in pulp, petroleum-based materials, energy, and transportation costs can erode margins. (2) Foreign Market Risks — International operations expose KMB to currency fluctuations, political, social, and economic instability. (3) Debt & Financing — KMB’s net debt to EBITDA ratio indicates moderate debt usage, but significant liabilities remain. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates KMB will report consensus revenue of $15.6B (-5.6% year-over-year) and EPS of $6.28 (-1.3% year-over-year) for the upcoming fiscal year. The following year, analysts project $14.4B in revenue.
A confirmed upcoming earnings date for KMB is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Kimberly-Clark Corporation (KMB) generated $2.6B in free cash flow over the trailing twelve months — a free cash flow margin of 15.6%. KMB returns capital to shareholders through dividends (5.1% yield) and share repurchases ($141M TTM).